Patient Group Directions (PGDs)

Patient Group Direction for the Urgent Provision of Medicines, Appliances and ACBS Products by Pharmacists Working Within NHS Grampian, Highland, Orkney, Shetland, Tayside and Western Isles, Version 32 (Expiry Date: October 2027)
Patient Group Direction For The supply of Trimethoprim tablets by Community Pharmacists (Pharmacy First Service) Version 3.0 (Expiry Date: August 2028)
Patient Group Direction for The Supply of Fusidic Acid Cream by Community Pharmacists (Pharmacy First Service), Version 3.0 (Expiry Date: August 2028)
Patient Group Direction for The Supply of Flucloxacillin for Skin Infections (Pharmacy First Service) Version 2.0 (Expiry Date: February 2027)
Patient Group Direction for The Supply of Aciclovir Tablets or Dispersible Tablets (Pharmacy First Service) Version 2.0 (Expiry Date: February 2027) – 
Patient Group Direction for The Supply of Nitrofurantoin MR Capsules / Immediate Release Capsules or Tablets to Non-Pregnant Patients (Pharmacy First Service) Version 3.0 (Expiry Date: August 2028)
Patient Group Direction for the Supply of Hydrocortisone 1% Cream Or Ointment, Version 1 (Expiry Date: January 2029)
  • PGD Hydrocortisone 1% Cream Or Ointment, V1.0 – Click here.
  • PGD Hydrocortisone 1% Cream Or Ointment, V1.0, Appendix 1Click here.
  • PGD Hydrocortisone 1% Cream Or Ointment, V1.0, Appendix 3Click here.
Patient Group Direction for the Supply of Nystatin Oral Suspension To Patients Aged 4 Weeks And Over For The Treatment Of Symptoms Of Oral Thrush, Version 1 (Expiry Date: March 2029)
  • PGD Nystatin Oral Suspension, V1 – Click here.
  • PGD Nystatin Oral Suspension Appendix 1Click here.
  • PGD Nystatin Oral Suspension Appendix 3Click here.
  • Patient Group Direction for the Supply of Beclometasone 50mg/Actuation Nasal Spray, V1 (Expiry Date – May 2026) – Click here
  • Patient Group Direction for the Supply of Fexofenadine 120mg Tablets, V1 (Expiry Date – May 2026) – Click here
  • Patient Group Direction for the Supply of Mometasone 50mg/Actuation Nasal Spray, V1 (Expiry Date – May 2026) – Click here
  • Patient Group Direction for the Supply of Olopatadine 1mg/mL Eye Drops, V1 (Expiry Date – May 2026) – Click here
  • Hayfever Individual Authorisation Form – Click here
  • Hayfever Patient Assessment Form – Click here
  • Hayfever Notification of Supply – Click here
Patient Group Direction’s for The Supply Of Ulipristal Acetate Emergency Contraception (UPA-EC), Levonorgestrel Emergency Contraception (LNG-EC). Desogestrel Progestogen-Only Contraceptive Pill (POP) and the Desogestrel Patient Assessment form are located on the Sexual Health webpage.
Patient Group Direction For The Administration of Adrenaline (Epinephrine) in Cases of Suspected Anaphylactic Reactions, V7.1 (Expiry Date: February 2027)
Patient Group Direction For The Supply of Azithromycin Tablets For Treatment of Uncomplicated Genital Chlamydia Infection Where First Line Treatment With Doxycycline Is Contraindicated By Pharmacists, V5 (Expiry Date: Nov 2027)
Patient Group Direction For The Supply of Doxycycline Capsules For Treatment of Uncomplicated Genital Chlamydia Infection By Pharmacists, Version 3 (Expiry Date: Nov 2027)
Patient Group Direction for the Administration or Supply of Oral Cholera Vaccine, Version 2.1 (Expiry Date: September 2027)
  • PGD Oral Cholera Vaccine, V2.1 – Click here.
  • PGD Oral Cholera Vaccine, Appendix 1 – Click here.
  • PGD Oral Cholera Vaccine, Appendix 2 – Click here.
Patient Group Direction for the Administration of Low Dose Diphtheria, Tetanus and Inactivated Poliomyelitis Vaccine (Td/IPV) (Revaxis), Version 2.1 (Expiry Date: December 2027)
  • PGD Low Dose Diphtheria, Tetanus and Inactivated Poliomyelitis Vaccine (Td/IPV) (Revaxis) V2.1 – Click here.
  • PGD Low Dose Diphtheria, Tetanus and Inactivated Poliomyelitis Vaccine (Td/IPV) (Revaxis), Appendix 1Click here.
  • PGD Low Dose Diphtheria, Tetanus and Inactivated Poliomyelitis Vaccine (Td/IPV) (Revaxis), Appendix 2Click here.
Patient Group Direction for the Administration of Hepatitis A Vaccine, Version 2.1 (Expiry Date: December 2027)
Patient Group Direction for the Administration of Hepatitis B Vaccine, Version 2.2 (Expiry Date: December 2027)
Patient Group Direction for the Administration of Combined Hepatitis A and B Vaccines, Version 2.3 (Expiry Date: December 2027)
Patient Group Direction for the Administration of Japanese Encephalitis Vaccine, Version 2.1 (Expiry Date: December 2027)
  • PGD Japanese Encephalitis, V2.1 – Click here.
  • PGD Japanese Encephalitis, Appendix 1 – Click here,
  • PGD Japanese Encephalitis, Appendix 2 – Click here.
Patient Group Direction for the Supply of Medicines Included In The Malaria Prophylaxis PGD Formulary, Version 2 (Expiry Date: June 2028)
Patient Group Direction for the Administration of Meningococcal ACWY Conjugate (MenACWY) Vaccine, Version 7.0 (Expiry Date: June 2028)
  • PGD Meningococcal Group (MenACWY) Conjugate Vaccine, V7.0 – Click here.
  • PGD Meningococcal Group (MenACWY) Conjugate Vaccine, Appendix 1 – Click here.
  • PGD Meningococcal Group (MenACWY) Conjugate Vaccine, Appendix 2 – Click here.
Patient Group Direction for the Administration of Rabies Vaccine, Version 2.1 (Expiry Date: December 2027)
Patient Group Direction for the Administration of Tick-Borne Encephalitis (TBE) Vaccine, Version 2.1 (Expiry Date: April 2028)
  • PGD Tick-Borne Encephalitis (TBE) Vaccine, V2.1 – Click here.
  • PGD Tick-Borne Encephalitis (TBE) Vaccine, Appendix 1 – Click here.
  • PGD Tick-Borne Encephalitis (TBE) Vaccine, Appendix 2 – Click here.
Patient Group Direction for the Administration of Typhoid Vi Vaccine (Injection), Version 2.2 (Expiry Date: December 2027)
  • PGD Typhoid Vi Vaccine (Injection) V2.2 – Click here.

Patient Group Direction for Measles, Mumps And Rubella (MMR) Live Vaccine, V2.2 (Expiry Date: December 2027)

PGD Measles, Mumps And Rubella (MMR) Live Vaccine V3.0 – Click here.

Other NHS Grampian Patient Group Directions (PGDs)

Patient Group Direction for Naloxone (Prenoxad® Or Nasal Spray) V6 (Expiry Date: April 2028)
  • PGD Naloxone (Prenoxad® Or Nasal Spray) V6 – Click here.
Patient Group Direction for the Administration of Pneumococcal Polysaccharide Vaccine (PPV) Pneumovax 23, V2.3 (Expiry Date: December 2028)
  • PGD Pneumococcal Polysaccharide Vaccine (PPV) Pneumovax 23, V2.3 – Click here.
Patient Group Direction for the Supply of Varenicline Tablets, V1 (Expiry Date: April 2028)